|
Diabetes, Vol 42, Issue 10 1506-1513, Copyright © 1993 by American Diabetes Association
GABA production in rat islets of Langerhans
M Michalik, J Nelson and M Erecinska
Department of Pharmacology, University of Pennsylvania, School of Medicine, Philadelphia 19104.
Homogenates of pancreatic islets catalyzed breakdown of L-glutamate to GABA
with a rate of 0.24 +/- 0.04 nmol.min-1 x mg-1 protein at 37 degrees C. The
formation of GABA was stimulated by addition of pyridoxal phosphate in the
range 0.05-1 microM (0.97 +/- 0.02 nmol.min-1 x mg protein-1 at a
saturating cofactor concentration), which indicates that the process was
catalyzed by glutamic acid decarboxylase. The half-maximal effect was
obtained with 0.1 microM PLP. Kinetic analyses of the results showed that
the Vmax and Km for the reaction were 1.12 nmol.min-1 x mg protein-1 and
0.66 mM, respectively. The pH optimum was 7.0. Subcellular fractionation
revealed that 51% of GAD activity was present in the cytosol, 17% in
microsomes, 9% in secretory granules, 5% in mitochondria, and 11% in cell
debris. Comparison of the kinetic properties of the cytosolic and
microsomal forms of the enzyme showed that their Km for glutamate was the
same, but that the cytosolic GAD had a lower Km for PLP. GABA synthesis in
the nominal absence of PLP was enhanced by malate (twofold increase at 5
mM) and citrate (threefold increase at 5 mM), but was unaffected by ATP and
chloride. However, if the islet homogenate was prepared and incubated in
the presence of PLP, neither malate nor citrate influenced enzyme activity.
Aspartate and AOA were powerful inhibitors of glutamate breakdown. Freshly
isolated islets contained approximately 4 mM GABA, whereas the
concentration was < 0.1 mM in whole pancreas.(ABSTRACT TRUNCATED AT 250
WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Wendt, B. Birnir, K. Buschard, J. Gromada, A. Salehi, S. Sewing, P. Rorsman, and M. Braun
Glucose Inhibition of Glucagon Secretion From Rat {alpha}-Cells Is Mediated by GABA Released From Neighboring {beta}-Cells
Diabetes,
April 1, 2004;
53(4):
1038 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bustamante, M. V. T. Lobo, F. J. Alonso, N.-T. A. Mukala, E. Gine, J. M. Solis, J. Tamarit-Rodriguez, and R. Martin Del Rio
An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin
Am J Physiol Endocrinol Metab,
December 1, 2001;
281(6):
E1275 - E1285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Park and H. J. Park
Effects of gamma -aminobutyric acid on secretagogue-induced exocrine secretion of isolated, perfused rat pancreas
Am J Physiol Gastrointest Liver Physiol,
October 1, 2000;
279(4):
G677 - G682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shi, J. Kanaani, V. Menard-Rose, Y. H. Ma, P.-Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, and S. Baekkeskov
Increased expression of GAD65 and GABA in pancreatic beta -cells impairs first-phase insulin secretion
Am J Physiol Endocrinol Metab,
September 1, 2000;
279(3):
E684 - E694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kanaani, D. Lissin, S. F. Kash, and S. Baekkeskov
The Hydrophilic Isoform of Glutamate Decarboxylase, GAD67, Is Targeted to Membranes and Nerve Terminals Independent of Dimerization with the Hydrophobic Membrane-anchored Isoform, GAD65
J. Biol. Chem.,
December 24, 1999;
274(52):
37200 - 37209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Rubi, H. Ishihara, F. G. Hegardt, C. B. Wollheim, and P. Maechler
GAD65-mediated Glutamate Decarboxylation Reduces Glucose-stimulated Insulin Secretion in Pancreatic Beta Cells
J. Biol. Chem.,
September 21, 2001;
276(39):
36391 - 36396.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1993 by the American Diabetes Association.
|
|
| |
|